Mastering the Supply Chain

After intense research investigations Heidelberg Pharma found a unique access to a fully synthetic route for α-Amanitin. With CARBOGEN AMCIS, Heidelberg Pharma developed a scalable and economical route providing α-Amanitin now available for the development of new therapeutic ADC’s.